MedPath

Validation of Ultrasound "Angle of Progression" Measurement to Decrease the Cesarean Rate

Not Applicable
Recruiting
Conditions
Prolonged Second Stage of Labor
Interventions
Diagnostic Test: Transperineal ultrasound measurements of AOP
Registration Number
NCT05779735
Lead Sponsor
Hospital St. Joseph, Marseille, France
Brief Summary

Ultrasound during labor and measurement of Angle of progression showed extensive prospective and retrospective publications since 2010. The investigators performed between 2013 and 2016 the only one multicenter, randomized controlled Trial comparing digital exam to angle of progression after a prolonged 2-hour second stage of labor with uncertain fetal head. The investigators consider a cut off of 120掳 to accepted vaginal birth among cephalic occiput anterior position This randomised PILOT study showed that measurement of Angle of progression in addition to digital exam reduced caesarean delivery from 41% to12% ( n= 33, p=0,06). doi: 10.1016/j.ajog.2022.04.018.

The objective of this new study is therefore to validate the results of this PILOT study in a more powerful multicenter randomized trial (DELIVERY).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
182
Inclusion Criteria
  • Nulliparous or multiparous women with no history of vaginal delivery,
  • > or = 37 weeks amenorrhoea
  • Cephalic presentation in anterior position (occipito-pubic position, left anterior occipito-iliac and right anterior occipito-iliac ) confirmed by ultrasound
  • uncertain fetal head engagement on digital examination or midline fetal presentation in prolonged second stage of labor (at least 2 hours),
Exclusion Criteria
  • Multiparous women who were previous vaginal deliveries,
  • Presentation other than cephalic,
  • Twin pregnancies,
  • Posterior or transverse position
  • Transperineal ultrasound for head-perineum distance measurement
  • Fetal heart rate abnormalities requiring rapid delivery,
  • Contraindication to vaginal delivery whether maternal or fetal

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 2 : Transperineal ultrasound measurements of AOPTransperineal ultrasound measurements of AOPThe mode of delivery will be determined by clinical examens (digital examination) and ultrasound measurement of the AOP : * vaginal delivery is encouraged if AOP measurement is \>120掳 * cesarean delivery is encouraged if AOP measurement is \<= 120掳
Primary Outcome Measures
NameTimeMethod
cesarean delivery ratebaseline

Demonstrate that the angle of progression measurement would change by 20% the cesarean rate after a prolonged second stage of labor (2 hours).

Secondary Outcome Measures
NameTimeMethod
Severe neonatal morbidity, in each group1 month

Severe neonatal morbidity, in each group, defined by the occurrence of at least one event below:

* severe biological signs

* moderate or absent biological signs but associated with perinatal events

* seizure

* severe neonatal trauma

* Fetal death or neonatal death.

Number of complicated deliveries in each groupbaseline

A complicated deliveries is defined by the occurrence of at least one of the following events :

* Failed instrumental extraction

* Sequential use of a second instrument,

* Difficult instrumental extraction defined as :

* vacuum detachment

* requires the use of a second instrument,

* extraction time \> 10 minutes,

* operator's impression of the difficulty of extraction,

* Shoulder dystocia by obstetric maneuver

Concordance rate between the routinely AOP measurement and the centralized AOP measurement reading1 month

Centralized blind AOP measurement reading

Severe maternal morbidity, in each group1 month

Severe maternal morbidity is defined by the occurrence of at least one of the following events:

* postpartum hemorrhage requiring hysterectomy, embolization, conservative surgical treatment or blood transfusion,

* third or fourth degree perineal tears

* vaginal thrombus,

* cervical tear,

* surgical wounds

* sepsis, amniotic embolism, cardiac complication or renal failure.

Rate of admission to neonatal intensive care unit, in each group1 month

Number of newborns admitted to intensive care out of the total number of newborns

Trial Locations

Locations (7)

CHU de Lille - H么pital Jeanne de Flandre

馃嚝馃嚪

Lille, France

APHM H么pital Conception

馃嚝馃嚪

Marseille, France

APHM H么pital Nord

馃嚝馃嚪

Marseille, France

H么pital Armand Trousseau AP-HP

馃嚝馃嚪

Paris, France

CHITS H么pital Sainte Musse

馃嚝馃嚪

Toulon, France

CHIC Poissy

馃嚝馃嚪

Poissy, France

Hopital Saint Joseph

馃嚝馃嚪

Marseille, France

漏 Copyright 2025. All Rights Reserved by MedPath